Learn more at LeadIQ.com

Insights

Strategic Partnerships Ossianix has established strategic partnerships with prominent companies such as Novo Nordisk and Lundbeck for research collaborations and delivery of therapeutic molecules, presenting potential sales opportunities through joint projects and product licensing agreements.

Innovative Technology The company's unique blood-brain-barrier shuttle technology offers a competitive edge in delivering proteins and peptides to the brain, attracting interest from organizations like the UKSPA and opening avenues for sales of this cutting-edge technology.

Key Personnel Expertise Founded by individuals with distinguished backgrounds in academia, Pharma, and Biotech, Ossianix benefits from a wealth of experience. Leveraging the expertise of its founders presents opportunities for sales through credibility and industry connections.

Market Leader Potential With a focus on neurodegeneration, neurooncology, ALS, pain, and botulism, Ossianix targets critical areas in the biotechnology sector. Being at the forefront of developing high-affinity biotherapeutic products positions the company as a potential market leader, offering sales opportunities as a preferred supplier for specialized treatments.

Biotech Networking Being part of the University City Science Center in Philadelphia and having research labs in the UK further expands Ossianix's network. Engaging with Biotech clusters and being part of renowned science parks opens doors for sales to a broad range of industry players seeking innovative biologics solutions.

Similar companies to Ossianix

Ossianix Tech Stack

Ossianix uses 8 technology products and services including Google Analytics, WordPress, Google Font API, and more. Explore Ossianix's tech stack below.

Google Analytics
Analytics
WordPress
Content Management System
Google Font API
Font Scripts
Font Awesome
Font Scripts
Hammer.js
Javascript Libraries
Modernizr
Javascript Libraries
jQuery Mobile
Mobile Frameworks
PHP
Programming Languages

Media & News

Ossianix's Email Address Formats

Ossianix uses at least 1 format(s):

Ossianix Email Formats	Example	Percentage
First@ossianix.com	John@ossianix.com	41%
FL@ossianix.com	JD@ossianix.com	11%
Last@ossianix.com	Doe@ossianix.com	7%
First@ossianix.com	John@ossianix.com	41%

Frequently Asked Questions

Where is Ossianix's headquarters located?

Ossianix's main headquarters is located at Stevenage Bioscience Catalyst Gunnels Wood Road Stevenage, Herts SG1 2FX GB. The company has employees across 1 continents, including Europe.

What is Ossianix's official website and social media links?

Ossianix's official website is ossianix.com and has social profiles on LinkedIn.

What is Ossianix's SIC code NAICS code?

Ossianix's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ossianix have currently?

As of October 2024, Ossianix has approximately 11 employees across 1 continents, including Europe. Key team members include Chief Executive Officer: F. W.Vice President Research: P. S.Co-Founder & Chief Scientific Officer: J. L. R.. Explore Ossianix's employee directory with LeadIQ.

What industry does Ossianix belong to?

Ossianix operates in the Biotechnology Research industry.

What technology does Ossianix use?

Ossianix's tech stack includes Google AnalyticsWordPressGoogle Font APIFont AwesomeHammer.jsModernizrjQuery MobilePHP.

What is Ossianix's email format?

Ossianix's email format typically follows the pattern of . Find more Ossianix email formats with LeadIQ.

When was Ossianix founded?

Ossianix was founded in 2012.

Ossianix

Ossianix

Biotechnology ResearchHerts, United Kingdom11-50 Employees

OSSIANIX, INC is a privately held pre clinical company that develops Biotherapeutic products using the highly versatile single domain VNAR antibody from the shark. The attractive biological and biophysical properties of the VNAR structure allows the rapid delivery of exquisitely high-affinity products to multiple target classes that have proven difficult or impossible by standard antibody approaches or alternative scaffolds.

The company is headquartered in the University City Science Center in downtown Philadelphia and has research laboratories at the Stevenage Bioscience Catalyst in Stevenage, Herts, UK. Ossianix was founded by Frank S Walsh, Corey Goodman and Lynn Rutkowski who have had distinguished careers in academia, Pharma and Biotech and bring a wealth of experience to the problem of delivering the next generation of Biologics products. The company started operations in 2012 with funding from Lundbeck Pharmaceuticals, BioAdvance and the ALS Association. Current programs focus on neurodegereration, neurooncology, ALS, pain and botulism.

Company Overview

Headquarters: Stevenage Bioscience Catalyst Gunnels Wood Road Stevenage, Herts SG1 2FX GB
Website: ossianix.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2012
Employees: 11-50

Media & News

Funding & Financials

Funding & Financials

Company Leadership

F. W.
Chief Executive Officer
✕
Access Insights for Ossianix and Millions of Other Companies
Sign up for full access to Ossianix information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Ossianix and Millions of Other Companies
Sign up for full access to Ossianix information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
P. S.
Vice President Research
✕
Access Insights for Ossianix and Millions of Other Companies
Sign up for full access to Ossianix information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Ossianix and Millions of Other Companies
Sign up for full access to Ossianix information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. L. R.
Co-Founder & Chief Scientific Officer
✕
Access Insights for Ossianix and Millions of Other Companies
Sign up for full access to Ossianix information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Ossianix and Millions of Other Companies
Sign up for full access to Ossianix information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. M.
Site Director & Operations Manager
✕
Access Insights for Ossianix and Millions of Other Companies
Sign up for full access to Ossianix information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Ossianix and Millions of Other Companies
Sign up for full access to Ossianix information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. G.
Senior Principal Scientist
✕
Access Insights for Ossianix and Millions of Other Companies
Sign up for full access to Ossianix information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Ossianix and Millions of Other Companies
Sign up for full access to Ossianix information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.